NORML

JANUARY 24, 2019

The bill would also allow Virginia’s licensed pharmaceutical processors to dispense medical cannabis preparations beyond the current definition of “oil” and in doses proven effective for the variety of disease processes for which doctors will recommend these therapies. Marijuana policy should be evidence based.

Policy

NORML

NOVEMBER 8, 2019

Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy. Will you send a message to your Member of Congress and tell them to join us as a cosponsor of HR 1151?

Access

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. NH resident? CO resident? NY resident?

Legislation

Veriheal

OCTOBER 13, 2023

Along with their medical properties, psychedelics’ low potential for abuse and psychological harm means legalization is just “good public policy” Sen. Ketamine Therapy For All? Enthea Thinks So Psychedelic therapy insurance provider Enthea is looking to bring ketamine-assisted therapy to the entire U.S. Irwin says.

Therapy

CannaTech

SEPTEMBER 23, 2019

The pleas of parents fighting to treat their sick children are impossible to ignore, as evidenced by the impact of Billy Caldwell and Alfie Dingley’s parents in shifting the regulatory framework for UK cannabis policy. UK cannabis policy is not serving the interests of patients.

Patients

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation

CannaEffect

JANUARY 26, 2017

As its medical components are further utilized and discovered, research and changes to statewide policies have rapidly progressed, promoting the plant’s widespread benefits. The post How Christina Evans Conquered Chronic Pain with Cannabis, Yoga Therapy appeared first on CannaEffect. Article Written by Leah Kennedy.

Chronic Pain

NORML

MARCH 14, 2019

A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction CAPS (Clinician Administered Post-traumatic Scale) symptom scores following cannabis therapy.

Access

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. Adult Oregonians will be able to access psilocybin therapy under the PSA beginning in January 2023; patients with advanced illness are among those who may benefit from this therapy.

Therapy

Veriheal

JANUARY 21, 2021

Although many of these athletes did not consume cannabis prior to games, fights, and other competitions but rather in their own free times, it did not matter as cannabis has been listed in many of the leagues’ anti-doping and drug policies since their inception. A Statement Regarding the Changes. Athletes That Have Come Forward.

Policy

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy

Cannabis Law Report

OCTOBER 20, 2021

International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021. International Psychedelic Therapies Summit 2021 MMA - Brief Outline 20102021. We are delighted to extend an invitation to you and your colleagues to join us ONLINE in November 2021. Here’s their full press release as a PDF.

Therapy

Cannabis Law Report

JULY 19, 2021

RYAH is a recognized leader in dose control technology for plant-based medicine, and we are pleased to be in a position to support the study and establish a new standardization of monitoring and measuring inhalation therapies in plant-based medicines,” said Gabriella Roda, researcher at the Department of Pharmaceuticals at the University of Milan.

Therapy

NORML

JUNE 13, 2019

Many are having serious difficulty calculating and covering annual expenses for marijuana therapy. No other state gets a place at the table – with the permit holders – for the price fix. This regulatory exercise could bring a new wave of relief to consumers.

Marijuana

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.

Legislation

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though. View original article.

Policy

CannaMD

MARCH 26, 2024

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law

NORML

FEBRUARY 13, 2019

Under existing regulations, VA doctors are not permitted to fill out the mandatory paperwork necessary to recommend cannabis therapy in those 33 states that regulate it.

Legislation

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Drugs: Education, Prevention and Policy , 28 (3), 211–214. Madison Natarajan, MS. – August 5, 2021. Thrul, J., & Garcia-Romeu, A. link] (Link). Source: [link].

Clinical Trials

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Legalization

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. Why Terpenes Are Vital To Your Cannabinoid Therapy. Privacy Policy and all Terms & Conditions printed on this site. By Rachael Maddison with Bradley Slaughter • 24 Apr, 2019. An intro to terpenes and how they work in hemp and cannabis. • 24 Apr, 2019.

Terpenes

Cannabis Law Report

JUNE 5, 2021

Among other questions, the poll asked: To what extent would you support or oppose the government relaxing restrictions on research into the medical use of magic mushroom-based treatments (psilocybin- assisted therapies) for mental health conditions if this didn’t affect how it was classified in criminal law (e.g. as a class A drug)?

Therapy

NORML

JANUARY 18, 2019

Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. AK resident? HI resident? CO resident? AZ resident?

Legislation

Cannabis Law Report

SEPTEMBER 10, 2021

Nick Milne PhD, Co-founder and CSO of Octarine said: “Our core ambition at Octarine is to advance psychedelic therapy across Europe and the world in a way that is consistent with sustainability principles while ensuring patient accessibility.

Research and Development

Canna Law Blog

FEBRUARY 19, 2020

The FDA already has granted “ breakthrough therapy ” status to a pair of psilocybin applicants for depression-related formulas, after approving another antidepressant designed to mimic hallucinogenic ketamine last year. This type of proposal envisions psilocybin-assisted therapy in controlled environments.

Decriminalization

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials

Veriheal

OCTOBER 20, 2021

Always consult a physician before attempting psychedelic therapy. These enlightening, natural therapies lead to smiles, munchies, laughter, and an overall enjoyable experience that many people are opting for over alcohol these days. Cannabis and magic mushrooms for the win! A Magical Future.

Therapy

Cannabis Law Report

NOVEMBER 11, 2021

The initiative also created the Denver Psilocybin Policy Review Panel (“Panel”), which was required to report back to the City on the public safety and other impacts of decriminalization. The City should determine how psilocybin therapy can be applied to address mental health issues in Denver. 2021-Comprehensive-Report.

Policy

Cannabis Law Report

JANUARY 5, 2022

W hile this Review focuses on 2021, it’s difficult to contextualise the levels of psychedelic drug policy reform witnessed this year without appreciating the gravitas of events in late 2020. Beyond progress updates on these two landmark initiatives, 2021 saw a flurry of policy reform efforts across the world. Introduction.

Policy

NORML

MARCH 14, 2020

The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder. 4522 was approved by the Joint Committee on Cannabis Policy on 3/9/20. 4524 was approved by the Joint Committee on Cannabis Policy on 3/9/20. Update : H. MA resident? Update : H.

Legislation

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. The final decision on the NCAA’s cannabis-policy changes is expected to come in the fall. Let’s dive into this week’s canna-news.

Clinical Trials

Veriheal

JUNE 19, 2023

Strict regulatory policies have led to the compulsory manufacture of synthetic psychedelic drugs. The report highlighted that “changes associated with psychedelic drug laws and policies are complicated and are resulting in changeable forms of application across different geographical areas.” It was approved by the U.S.

Therapy

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?

Law

Cannabis Law Report

FEBRUARY 14, 2023

There’s been significant interest in psychedelics policy in the Aloha State this […] Marijuana Moment Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of psilocybin, MDMA and other alternative treatments for mental health conditions.

Therapy